Here, we have shown for the first time that C12orf59 is a putative oncogene in ESCC and exerts its oncogenic role by modulating the activity of YAP, which is a well-known oncoprotein recognized as the main downstream effector of the Hippo pathway (33, 34). Here, TMEM52B is linked to esophageal squamous cell carcinoma.